Dermata Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DRMA and other ETFs, options, and stocks.About DRMA
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410.
CEOGerald T. Proehl
CEOGerald T. Proehl
Employees8
Employees8
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2014
Founded2014
Employees8
Employees8
DRMA Key Statistics
Market cap2.21M
Market cap2.21M
Price-Earnings ratio-0.11
Price-Earnings ratio-0.11
Dividend yield—
Dividend yield—
Average volume356.86K
Average volume356.86K
High today$2.31
High today$2.31
Low today$2.13
Low today$2.13
Open price$2.30
Open price$2.30
Volume38.19K
Volume38.19K
52 Week high$23.70
52 Week high$23.70
52 Week low$2.13
52 Week low$2.13
Stock Snapshot
As of today, Dermata Therapeutics(DRMA) shares are valued at $2.18. The company's market cap stands at 2.21M, with a P/E ratio of -0.11.
As of 2025-12-19, Dermata Therapeutics(DRMA) stock has fluctuated between $2.13 and $2.31. The current price stands at $2.18, placing the stock +2.2% above today's low and -5.7% off the high.
Dermata Therapeutics(DRMA) shares are trading with a volume of 38.19K, against a daily average of 356.86K.
During the past year, Dermata Therapeutics(DRMA) stock moved between $2.13 at its lowest and $23.70 at its peak.
During the past year, Dermata Therapeutics(DRMA) stock moved between $2.13 at its lowest and $23.70 at its peak.
People also own
Based on the portfolios of people who own DRMA. This list is generated using Robinhood data, and it’s not a recommendation.